FDA.reportPublic FDA data

Ojemda 300 MG per 12 ML Powder for Oral Suspension

RxCUI
2682445
RxNorm name
Ojemda 300 MG per 12 ML Powder for Oral Suspension
Display name
Ojemda 300 MG per 12 ML Powder for Oral Suspension
Full name
Ojemda 300 MG per 12 ML Powder for Oral Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OJEMDATOVORAFENIBDay One Biopharmaceuticals, Inc.ea3a9631-3a66-6a7c-e053-2995a90ae2ad2025-09-02Warnings, Adverse reactionsExact identifier
rxcui: 2682445

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
ea3a9631-3a66-6a7c-e053-2995a90ae2adojemda 25 MG in 1 mL Powder for Oral Suspension [PSN] · tovorafenib 300 MG Powder for Oral Suspension [Ojemda] [SBD] · Ojemda 25 MG per 1 ML Powder for Oral Suspension [SY] · Ojemda 300 MG per 12 ML Powder for Oral Suspension [SY] · Ojemda 300 MG Powder for Oral Suspension [SY]59These highlights do not include all the information needed to use OJEMDA safely and effectively. See full prescribing information for OJEMDA. OJEMDA (tovorafenib) tablets, for oral use OJEMDA (tovorafenib) for oral suspension Initial U.S. Approval: 202420250902